medigraphic.com
SPANISH

Archivos de Medicina de Urgencia de México

ISSN 2594-3006 (Electronic)
ISSN 2007-1752 (Print)
Archivos de Medicina de Urgencia de México
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2025, Number 1

<< Back Next >>

Arch Med Urg Mex 2025; 17 (1)

Clinical presentation, diagnosis, and treatment of patients with diabetic ketoacidosis during pregnancy and the postpartum period treated in a tertiary care unit

Díaz-Aguilar FA, Reyes-Miranda RA, Chablé-Chan FG, Gurrola-Gómez CA, Calva-Salinas KL, Helue-Mena A
Full text How to cite this article 10.35366/120930

DOI

DOI: 10.35366/120930
URL: https://dx.doi.org/10.35366/120930

Language: Spanish
References: 20
Page: 15-24
PDF size: 310.24 Kb.


Key words:

Diabetic ketoacidosis, pregnancy, puerperium.

ABSTRACT

Introduction: diabetic ketoacidosis (DKA) during pregnancy and the postpartum period represents a critical medical complication with serious implications for maternal and fetal health. Despite its severity, there are limitations in knowledge about its clinical characteristics, diagnosis, and management in specialized hospital settings. Given the variability in global incidence and the significant associated risks, it is imperative to explore these aspects in depth to optimize care and improve outcomes.
Objective: to describe the clinical picture, diagnosis, and treatment of patients with diabetic ketoacidosis during pregnancy and the postpartum period who were treated in the intensive care unit of the Gynecology and Obstetrics Hospital No. 3 “Dr. Víctor Manuel Espinosa de los Reyes Sánchez” of the National Medical Center “La Raza”.
Material and methods: this is an analytical, observational, retrospective, descriptive, and longitudinal study; It is based on the review of clinical records of patients diagnosed with DKA during pregnancy and the postpartum period, treated from January 2019 to June 2024. The American Diabetes Association (ADA) criteria for the diagnosis of DKA were applied (pH ‹7.30, blood glucose ›200 mg/dL, positive ketonuria) and the information was taken from the records using a data collection sheet, without including identifiable information.
Results: nine cases were included. The median age was 27 years (IQR 22 - 37), gestational age at presentation was 28.6 weeks (IQR 18.6 - 37), with five patients (55.6%) diagnosed in the third trimester. The type of diabetes: type 1 diabetes mellitus (DM1) in 44.4%, gestational 33.3% and type 2 diabetes mellitus (DM 2) in 22.2%. The time of evolution of diabetes was less than 1 year in 66.7%. The most frequent comorbidity was obesity (33.3%). Lack of adherence to treatment was the most frequent precipitating factor (66.6%). Within the clinical picture that occurred most frequently: náuseas (77.8%) and vomiting (66.7%). Management in the ICU after 12 hours of stay, showed significant improvement in: heart rate (112 bpm vs 90 bpm, p = 0.98), pH (7.25 vs 7.37, p = 0.001), bicarbonate (11.8 mmol / L vs 16.4 mmol / L, p = 0.005), base excess (-18.1 mmol / L vs -11.1 mmol / L, p = 0.001) and the anion gap (17.2 vs 11 mmol / L, p = 0.007). Medical treatment: no one received insulin loading; insulin infusion dose used during the 12 hours was 0.040 IU/kg/h (IQR 0.014 – 0.055) and fluids infused in 12 hours was 3000 mL (IQR 1555 mL – 3391.5 mL). 66.7% of patients were discharged from the ICU after 2 days of stay.
Conclusion: diabetic ketoacidosis in pregnancy and puerperium is more frequently manifested in DM1 and gestational diabetes precipitated by the lack of metabolic control and a duration of diabetes less than one year. The predominant clinical picture is náuseas and vomiting; the management received in 12 hours includes fluids and intravenous insulin infusion, achieving discharge after 2 days of care.


REFERENCES

  1. Lizzo JM, Goyal A, Gupta V. Adult Diabetic Ketoacidosis. En: StatPearls[Internet] [Internet]. StatPearls Publishing; 2023 [citado 12de octubre de 2024]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK560723/

  2. Dhatariya KK, Glaser NS, Codner E, Umpierrez GE. Diabetic ketoacidosis.Nat Rev Dis Primer. 14 de mayo de 2020;6(1):1-20.

  3. Eledrisi MS, Beshyah SA, Malik RA. Management of diabetic ketoacidosisin special populations. Diabetes Res Clin Pract. 1 deabril de 2021;174:108744.

  4. Sharma AK, Singh S, Singh H, Mahajan D, Kolli P, Mandadapu G,et al. Deep Insight of the Pathophysiology of Gestational DiabetesMellitus. Cells. enero de 2022;11(17):2672.

  5. Diguisto C, Strachan MWJ, Churchill D, Ayman G, Knight M. Astudy of diabetic ketoacidosis in the pregnant population in theUnited Kingdom: Investigating the incidence, aetiology, managementand outcomes. Diabet Med. 2022;39(4):e14743.

  6. Eshkoli T, Barski L, Faingelernt Y, Jotkowitz A, Finkel-Oron A,Schwarzfuchs D. Diabetic ketoacidosis in pregnancy – Case series,pathophysiology, and review of the literature. Eur J ObstetGynecol Reprod Biol. 1 de febrero de 2022;269:41-6.

  7. Sibai BM, Viteri OA. Diabetic Ketoacidosis in Pregnancy. ObstetGynecol. enero de 2014;123(1):167-78.

  8. Cabrera-Figueredo I, Luaces-Sánchez P, Cruz-Fernández CYde la, González-Reigada A, Cabrera-Figueredo I, Luaces-SánchezP, et al. Cetoacidosis diabética normoglucémica en mujerescon diabetes gestacional. Rev Arch Méd Camagüey[Internet]. abril de 2020 [citado 25 de octubre de 2024];24(2). Disponibleen: http://scielo.sld.cu/scielo.php?script=sci_abstract&pid=S1025-02552020000200013&lng=es&nrm=iso&tlng=es

  9. Stern C, Schwarz S, Moser G, Cvitic S, Jantscher-Krenn E,Gauster M, et al. Placental Endocrine Activity: Adaptation andDisruption of Maternal Glucose Metabolism in Pregnancy andthe Influence of Fetal Sex. Int J Mol Sci. 24 de noviembre de2021;22(23):12722.

  10. Rassie K, Giri R, Joham AE, Teede H, Mousa A. Human PlacentalLactogen in Relation to Maternal Metabolic Health and Fetal Outcomes:A Systematic Review and Meta-Analysis. Int J Mol Sci.enero de 2022;23(24):15621.

  11. Urbina-Quispe K, Corcuera-Ciudad R, Minchola-Vega J, NovoaRH, Urbina-Quispe K, Corcuera-Ciudad R, et al. Presentaciónmixta de cetoacidosis diabética y estado hiperosmolar hiperglucémicoen el embarazo: reporte de caso. Ginecol Obstet México.2022;90(3):273-8.

  12. Spencer NR, Clark SM, Harirah HM. Management of DiabeticKetoacidosis in Pregnancy. Clin Obstet Gynecol. marzo de2023;66(1):186.

  13. Dhanasekaran M, Mohan S, Erickson D, Shah P, Szymanski L,Adrian V, et al. Diabetic Ketoacidosis in Pregnancy: Clinical RiskFactors, Presentation, and Outcomes. J Clin Endocrinol Metab. 2de agosto de 2022;107(11):3137.

  14. ENCUESTA NACIONAL DE LA DINÁMICA DEMOGRÁFICA(ENADID) 2023. 2024;

  15. Ginecología y Obstetricia de México [Internet]. [citado 25 de octubrede 2024]. Ginecología y Obstetricia de México. Disponible en:https://ginecologiayobstetricia.org.mx/articulo/cetoacidosis-diabetica-durante-el-embarazo-reporte-de-un-caso

  16. Veciana MD. Diabetes ketoacidosis in pregnancy. Semin Perinatol.agosto de 2013;37(4):267-73.

  17. ACOG Practice Bulletin No. 201: Pregestational Diabetes Mellitus.Obstet Gynecol. diciembre de 2018;132(6):e228.

  18. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM,Bruemmer D, et al. 2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023. Diabetes Care. 12 de diciembrede 2022;46(Supplement_1):S19-40.

  19. Grasch JL, Lammers S, Scaglia Drusini F, Vickery SS, VenkateshKK, Thung S, et al. Clinical Presentation and Outcomes of DiabeticKetoacidosis in Pregnancy. Obstet Gynecol. noviembre de

  20. 2024;144(5):590.20. Rodríguez DGP. UNIDAD DE ATENCION MÉDICA.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Arch Med Urg Mex. 2025;17